Tag: Prescription Drugs
Adverse Drug Reactions Linked to Hydroxychloroquine Up in 2020
ADRs associated with hydroxychloroquine, chloroquine more than doubled in 2020 versus 2018 and 2019
COVID-19 Outcomes No Worse for Patients on Immunosuppressive Meds
Findings for ventilator use, length of stay, in-hospital mortality similar for those with, without chronic use of immunosuppressant agents
No Evidence Found to Support Discontinuing ACEIs, ARBs in COVID-19
Mean number of days alive and out of hospital not significantly different for those discontinuing, continuing meds
Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild-to-moderate COVID-19
FDA Approves First Monthly Injectable Regimen for HIV
Trials show virologic suppression in comparable numbers of patients receiving monthly injection with Cabenuva, daily current antiretroviral regimen
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Denosumab Studied for Prosthesis-Related Osteolysis
Fewer osteoclasts seen at osteolysis membrane-bone interface with denosumab versus placebo in patients undergoing revision hip arthroplasty
Continuing Blood Pressure Meds Safe for Those With COVID-19
No difference in outcomes seen among hospitalized COVID-19 patients continuing, discontinuing renin-angiotensin system inhibitors
USPSTF Affirms Evidence-Based Methods for Smoking Cessation
Behavioral and pharmacotherapy interventions, alone or in combination, recommended; evidence insufficient for e-cigarettes
